The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
Self-collection devices designed for ease of use and safety
Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
Thermo Fisher’s kits leverage an updated design from the original TaqPath assays, targeting eight different genes across three regions of the virus that causes Covid-19
Subscribe To Our Newsletter & Stay Updated
